title: Randomized trial of a comparison of rehabilitation or drug therapy for urgency urinary incontinence: 1-year follow-up.
abstract: OBJECTIVE
  Our goal was to compare the long-term efficacy of bladder training (BT), pelvic floor muscle training (PFMT), combined pelvic floor rehabilitation (CPFR), and drug therapy (DT) in patients with urgency urinary incontinence (UUI).
  
  
  METHODS
  This multicenter single-blind randomized controlled trial compared the efficacy of BT, PFMT, DT, and CPFR at baseline and 3- and 12-month follow-ups. Outcome measures included number of voids/24 h, number of UUI episodes, Quality of Life related to UUI (QOL-rUI), urogynecologic visual analog scale, and self-reported function and disability.
  
  
  RESULTS
  A significant improvement was found for all treatment groups at 3 and 12 months in urinary frequency, UUI episodes, QOL-rUI, and number of daily pads. Only CPFR showed a significant decrease of 4 voids/24 h and a significant increase in self-reported function.
  
  
  CONCLUSIONS
  The study demonstrated long-term benefits of DT, BT, PFMT, and CPFR in the treatment of UUI with a slight advantage for CPFR.
authors.affiliation: Department of Physical Therapy, Schwartz Movement Analysis & Rehabilitation Laboratory, Physical Therapy Department, Recanati School for Community Health Professions, Faculty of Health Science, Ben-Gurion University of Negev, PO Box 653, Beer-Sheva 84105, Israel.
authors.forename: Rachel
authors.initials: R
authors.lastname: Kafri
authors.forename: Daniel
authors.initials: D
authors.lastname: Deutscher
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Shames
authors.forename: Jacob
authors.initials: J
authors.lastname: Golombp
authors.forename: Itshak
authors.initials: I
authors.lastname: Melzer
mesh_terms: D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D003408:Cresols / Q000627:therapeutic use*; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D018579:Patient Selection; D017773:Pelvic Floor / Q000502:physiology*; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D000068737:Tolterodine Tartrate; D016896:Treatment Outcome; D053202:Urinary Incontinence, Urge / Q000188:drug therapy / Q000534:rehabilitation*; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D001559:Benzhydryl Compounds; D003408:Cresols; D064804:Urological Agents; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate